drugset / Trial / NCT01016691

Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691

Phase 2 Completed 47 enrolled Vistakon Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.

Timeline

Start
2009-10
Primary completion
2010-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Bimatoprost Other / unclassified 0.03 % Other
Background Bimatoprost Other / unclassified 45 ug Other
Background Bimatoprost Other / unclassified 65 ug Other